Informed Consent to Psychedelic Medicine.
Am J Ther January 1, 2025 DOI: 10.1097/mjt.0000000000001782 (opens in new tab) via PubMed
Summary
AI-generated from the abstractThe article examines the unique challenges of obtaining informed consent for psychedelic medicine, arguing that the altered states of consciousness induced by these substances complicate standard consent processes. It explores how the profound, often unpredictable experiences during psychedelic therapy affect patients' decision-making capacity and autonomy. The author suggests that traditional consent models may be insufficient and proposes ethical frameworks to address these issues, emphasizing the need for enhanced communication, realistic expectations, and ongoing consent throughout treatment. The piece contributes to the ethical discourse on psychedelic-assisted therapy by highlighting the tension between therapeutic potential and patient protection.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key finding | Argues that informed consent for psychedelic medicine requires a specialized approach that accounts for the unique psychological and existential dimensions of psychedelic experiences. |
Abstract
Informed Consent to Psychedelic Medicine.